Nan Cao

2PUBLICATIONS
25CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 24, 2026
Safety, Tolerability, and Pharmacokinetics of HBM9378 (SKB378/WIN378), a Fully Human IgG1 Monoclonal Antibody Against TSLP After Single Ascending Doses in Chinese Healthy Subjects.

Xiaojia Yang, Min Xu, Nan Cao

|May 16, 2025
Porustobart (HBM4003) plus Toripalimab as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma: A Multicenter, Open-Label, Phase I Study.

Ningning Zhang, Tian Liu, Ming Luo

Pageof 1

Frequent Collaborators

1 joint publications

Ningning Zhang

1 joint publications

Tian Liu

1 joint publications

Ming Luo

1 joint publications

Jihui Hao